AI Use Needs Docs' Consent | ColoSense Shows 94.4% Sensitivity For CRC

AI Use Needs Docs' Consent | ColoSense Shows 94.4% Sensitivity For CRC

AMA: Some AI Use in Medicine Should Require Docs' Consent (Medscape)

The AMA calls for physician consent in some AI uses in medicine, advocating for limited physician liability and greater transparency in insurers' AI decision-making systems.


Image credit: BCBS Massachusetts

Upcoming BCBSMA changes could have 'chilling effects' on GI patient care (Becker's GI & Endoscopy)

Blue Cross Blue Shield Massachusetts' new policy will stop covering monitored anesthesia care for some GI procedures without specific risk factors, possibly affecting patient care and efficiency.


Noninvasive Multitarget Stool RNA Test Proves Sensitive for Colorectal Cancer, Advanced Adenomas (DocWire News)

The ColoSense multitarget stool RNA test demonstrates high sensitivity for detecting colorectal cancer and advanced adenomas, offering a promising noninvasive screening option.


When it Comes to Treating Ulcerative Colitis, US Gastroenterologists May be Betting it All on JAK (Yahoo Finance)

JAK inhibitors, led by AbbVie’s Rinvoq, are increasingly used in ulcerative colitis treatment in the US, challenging traditional therapies.


Vitamin D Linked to Clinical, Endoscopic Outcomes of Vedolizumab Treatment for IBD (HCP Live)

Higher vitamin D levels before treatment improved colonoscopy results in ulcerative colitis and led to better nutrition and supplementation in Crohn disease patients.


Image credit: Oshi Health

Research Shows Reduced Emergency Department Utilization from Patients Accessing Oshi Health Virtual Multidisciplinary GI Care (PR Newswire)

At 3 and 6 months, enrolled patients showed a 72% and 64% reduction in GI-related emergency department visits compared to non-enrolled patients, with rates dropping from 17% to 5% and 21% to 8%, respectively.


New study provides evidence for three-year interval for multi-target stool DNA screening for those at average risk of colon cancer (Regenstrief Institute)

A study found no colorectal cancers three years after a negative multi-target stool DNA test, suggesting a three-year interval for such screenings is clinically appropriate.


First-of-Its-Kind 4K Single-Use Surgical Arthroscope Simplifies Endoscopy (HospiMedica.com)

Pristine Surgical has expedited the release of its Summit 4K single-use surgical arthroscope to enhance the efficiency, consistency, and safety of endoscopy procedures.


What gastroenterologists are prioritizing in 2024 (Becker's GI & Endoscopy)

In 2024, gastroenterologists are focusing on staff engagement, contract management, and exploring the impact of AI in gastroenterology, including its use in colon cancer screening and Barrett's esophagus surveillance.


Flexible parental leave policies increase inclusivity, reduce burnout in GI (Healio)

Elizabeth Paine, MD, outlines how having clear and thorough parental leave policies promotes inclusivity and job retention in gastroenterology.


Gastroenterology Month in Review: November 2023 (HCPLive)

November 2023 in gastroenterology featured an FDA approval for erosive esophagitis treatment, discontinuation of a phase 3 ulcerative colitis program, and insights into Clostridioides difficile testing and risk factors.


Embracing change in patient care: Top trends shaping 2024 (Health Data Management)

Emerging initiatives gain momentum as organizations explore the future of virtual care, personalized genomics and patient-centric approaches.



For weekly gastroenterology business/tech updates directly in your inbox, subscribe to the?Scope Forward newsletter.

Get the book:?Scope Forward - The Future of Gastroenterology Is Now In Your Hands.


要查看或添加评论,请登录

社区洞察

其他会员也浏览了